Cyfuse Biomedical K.K. (TYO:4892)
Japan
· Delayed Price · Currency is JPY 711.00
+1.00 (0.14%)
Apr 28, 2026, 3:30 PM JST
Cyfuse Biomedical K.K. Company Description
Cyfuse Biomedical K.K. develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States.
The company offers the Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves; regenova, a 3D software that creates 3D data where spheroids shall be mounted; and S-PIKE that develops 3D-structures from cells.
It also provides the Human 3D Mini-Liver, an in vitro MASH model that recapitulates human liver functions and predicts efficacy of drugs.
Cyfuse Biomedical K.K. was incorporated in 2010 and is headquartered in Minato, Japan.
Cyfuse Biomedical K.K.
| Country | Japan |
| Founded | 2010 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 23 |
| CEO | Shizuka Akieda |
Contact Details
Address: South Tower, Sumitomo Fudosan Tokyo Mita Minato, 108-6301 Japan | |
| Phone | 81 3 6435 1885 |
| Website | cyfusebio.com |
Stock Details
| Ticker Symbol | 4892 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3311800001 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Shizuka Akieda | Chief Executive Officer |
| Masahiro Sanjo | Chief Financial Officer |